The Bank of Japan remains unchanged, providing assistance to the booming global stock market.
The Bank of Japan remains unchanged, indicating that it will not rush to continue tightening monetary policy after the unexpected rate hike in July.
Johnson & Johnson Gets FDA Approval for Non-Small Cell Lung-Cancer Treatment
Express News | FDA Approves Amivantamab-Vmjw With Carboplatin and Pemetrexed for Non-Small Cell Lung Cancer With Egfr Exon 19 Deletions or L858R Mutations
Express News | J&J Lifts Baby Powder Settlement Bid to More Than $8.2 Billion - Bloomberg News
Express News | Johnson & Johnson has increased its offer for baby powder and settlements to over $8.2 billion.
Cantor Fitzgerald Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $215
Cantor Fitzgerald analyst Louise Chen maintains $Johnson & Johnson(JNJ.US)$ with a buy rating, and maintains the target price at $215.According to TipRanks data, the analyst has a success rate of 42.6
Johnson & Johnson Commemorates 50 Years in Singapore With a Series of Events Marking a Remarkable Milestone
BeiGene Initiated at Outperform at JMP Securities on Strength of Brukinsa
Citi Maintains Johnson & Johnson(JNJ.US) With Buy Rating
Citi analyst Joanne Wuensch maintains $Johnson & Johnson(JNJ.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 63.8% and a total average return of 6.4% over the
Johnson & Johnson (JNJ) Faces Legal Challenges While Advancing MedTech Innovations for Growth
U.S. To J&J: Don't Target Hospital Drug Discounts -- WSJ
Sector Update: Health Care Stocks Steady Premarket Tuesday
Sector Update: Health Care
A judge in Oregon overturned the verdict of the Johnson & Johnson talcum powder case and ordered a retrial.
On September 17th, according to Reuters, a judge in Oregon overturned a jury's decision to award $0.26 billion in compensation to Johnson & Johnson. The plaintiff in the lawsuit claimed to have developed mesothelioma, a fatal cancer related to asbestos exposure, from inhaling the company's talcum powder. According to a spokesperson for Johnson & Johnson, Judge Katharine von ter Stegge in Portland approved the company's motion to overturn the verdict and ordered a new trial. Written opinions are expected to be released in the next few days. The Vice President of Global Litigation at Johnson & Johnson is responsible for the litigation.
This Johnson & Johnson Insider Reduced Their Stake By 37%
CG Oncology Surges 7%; Seen Benefitting From J&J Bladder Cancer Asset Data
Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target
Johnson & Johnson Analyst Ratings
Johnson & Johnson Says Its Bladder Cancer Drug Combined With Cetrelimab Shows High Response Rate in Study
Express News | J&J - Shockwave Medical, Announced Full U.S. Launch of Shockwave E8 Peripheral Ivl Catheter